| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |